Locations:

Heart Failure & Transplant

23-HVI-3853877_impella-heart-illustration_650x450

May 22, 2023/Heart, Vascular and Thoracic/Heart Failure & Transplant

Impella Support Fails to Improve Outcomes of VT Ablation in High-Risk Heart Failure Patients

Further study needed to assess potential role in select subgroups

October 26, 2022/Heart, Vascular and Thoracic/Heart Failure & Transplant

A Close-Up Look at Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired LV Function

Large cohort study finds widespread LV impairment and details racial and genetic differences

April 14, 2022/Heart, Vascular and Thoracic/Heart Failure & Transplant

A New Take on Heart Failure: Emerging Interventional Approaches

Snapshots of four interventional therapies in clinical testing

December 10, 2021/Heart, Vascular and Thoracic/Heart Failure & Transplant

PDE-5 Inhibitors May Benefit Patients After Centrifugal-Flow LVAD Implant

Outcome benefits from large registry lay groundwork for a randomized controlled trial

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

21-HVI-2104548-CQD-Legalized-Cannabis-and-Heart-Transplant

May 24, 2021/Heart, Vascular and Thoracic/Heart Failure & Transplant

Cannabis Use Is a Growing Concern in Heart Transplant

Literature review summarizes existing data to help inform international guidelines

January 15, 2021/Heart, Vascular and Thoracic/Heart Failure & Transplant

ALIVE Trial Offers Hybrid Approach for Ischemic Cardiomyopathy With Residual Scar

Minimally invasive percutaneous/surgical procedure reshapes the heart

BackPage 2 of 2Next